The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.

Doreen A EzeifeEldon SpackmanRosalyn A JuergensJanessa J LaskinJason S AgulnikDesiree HaoScott A LaurieJennifer H LawLisa W LeLesli A KiedrowskiBarbara L MeloskyFrances A ShepherdVictor CohenPaul Wheatley-PriceRachel VandermeerJanice Juan Ning LiRoxanne FernandesAria ShokoohiRichard B LanmanNatasha B Leighl

Published in: Therapeutic advances in medical oncology (2022)

The addition of LB to TT as initial molecular testing of clinically selected patients with advanced NSCLC did not increase system costs and led to more patients receiving appropriate targeted therapy.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
ultrasound guided
single cell
fine needle aspiration
copy number
single molecule
tyrosine kinase
small cell lung cancer
gene expression
life cycle
dna methylation
genome wide
light emitting